Cytognomix, the company co-founded by Dr. Peter Rogan in the Dept. of Biochemistry, has received a contract from the Build in Canada Innovation Program of the federal government. The investment is for innovative software that detects radiation exposure in human chromosomes. This announcement has been featured in The London Free Press and by CBC News. For more info, see Press Release.